Linear and nonlinear system approaches in pharmacokinetics: How much do they have to offer? II. The response mapping operator (RMO) approach
暂无分享,去创建一个
Harold Boxenbaum | Peter Veng-Pedersen | Ronald A. Siegel | Carl M. Metzler | R. Siegel | H. Boxenbaum | C. Metzler | P. Veng‐Pedersen
[1] L. Benet,et al. General treatment of linear mammillary models with elimination from any compartment as used in pharmacokinetics. , 1972, Journal of pharmaceutical sciences.
[2] A note on appropriate constraints on the initial input response when applying deconvolution , 1986, Journal of Pharmacokinetics and Biopharmaceutics.
[3] A. Rescigno. Chapter 5 – COMPARTMENTS , 1972 .
[4] N. Modi,et al. A system approach to pharmacodynamics. Input-effect control system analysis of central nervous system effect of alfentanil. , 1993, Journal of pharmaceutical sciences.
[5] P. Meredith,et al. Pharmacokinetic and pharmacodynamic modelling of trimazosin and its major metabolite , 1983, Journal of pharmacokinetics and biopharmaceutics.
[6] Aldo Rescigno,et al. The use and abuse of models , 1987, Journal of Pharmacokinetics and Biopharmaceutics.
[7] Ludwig von Bertalanffy,et al. The History and State of General Systems Theory , 1972 .
[8] Peter Veng Pedersen,et al. Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT , 1977, Journal of Pharmacokinetics and Biopharmaceutics.
[9] P. Veng‐Pedersen. Linear and nonlinear system approaches in pharmacokinetics: How much do they have to offer? I. General considerations , 1988, Journal of Pharmacokinetics and Biopharmaceutics.
[10] L. Benet,et al. Pharmacokinetics of cefamandole using a HPLC assay , 1978, Journal of Pharmacokinetics and Biopharmaceutics.
[11] P. Veng‐Pedersen,et al. A system approach to pharmacodynamics. II: Glyburide pharmacodynamics and estimation of optimal drug delivery. , 1988, Journal of pharmaceutical sciences.
[12] Ewart R. Carson,et al. Mathematical modeling of dynamic biological systems , 1979 .
[13] Sidney Addelman,et al. trans-Dimethanolbis(1,1,1-trifluoro-5,5-dimethylhexane-2,4-dionato)zinc(II) , 2008, Acta crystallographica. Section E, Structure reports online.
[14] W. Colburn. Pharmacokinetic/pharmacodynamic modeling: What it is! , 1987, Journal of Pharmacokinetics and Biopharmaceutics.
[15] P. Veng‐Pedersen,et al. A system approach to pharmacodynamics. I: Theoretical framework. , 1988, Journal of pharmaceutical sciences.